Journal Club February 2026

This month's Journal Club highlights key developments in preventive health and child development. We examine how different forms of COVID-19 vaccine hesitancy predict actual uptake, with trust-based concerns proving most resistant to change. A landmark trial demonstrates that fremanezumab significantly reduces migraine frequency in children, offering a promising new preventive option. We explore how cow's milk protein allergy in infancy may shape eating behaviors years later, and investigate the complex U-shaped relationship between social media use and adolescent well-being. Finally, we review encouraging evidence that early parenting support programs can yield measurable academic benefits through age six.